IDDA-Scored Abatacept-to-HSCT Course in Pediatric LRBA Deficiency
Journal of Clinical Immunology · 14.11.2026
DOI: 10.1007/s10875-026-02092-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 14.11.2026. Verfasst von Bin Hu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
LRBA deficiency is a rare inborn error of immunity in which impaired CTLA-4 recycling causes immune dysregulation; haematopoietic stem cell transplantation (HSCT) is curative, but no standardised measure of pre-transplant disease activity exists and the role of abatacept as a bridge to HSCT remains ill-defined. We report a 4-year-old girl with compound heterozygous LRBA variants in whom abatacept, given as a planned bridge to transplantation, reduced disease activity within four months (Immune Deficiency and Dysregulation Activity [IDDA] score 54.5 to 22.6), maintained control until transplant, and was followed by an IDDA of 1.0 at 22 months after HLA-matched unrelated-donor HSCT. Retrospective IDDA scoring was feasible in 32 of 46 published LRBA HSCT patients (22 with and 10 without pre-HSCT abatacept; baseline scores 11.1 vs. 11.5): overall survival was numerically higher in abatacept-exposed patients (95.8% [23/24] vs. 86.4% [19/22]); the difference was not statistically significant (Fisher exact P = 0.34), and the comparison is descriptive, underpowered, and hypothesis-generating only. The IDDA provides a practical metric to quantify disease activity and to evaluate the contribution of pre-HSCT abatacept in LRBA deficiency.
Zitieren
APA
Hu, B., Wang, Z., Zhang, Y., Teng, L., & Lu, M. (2026). IDDA-Scored Abatacept-to-HSCT Course in Pediatric LRBA Deficiency. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-026-02092-0
Vancouver
Hu B, Wang Z, Zhang Y, Teng L, Lu M. IDDA-Scored Abatacept-to-HSCT Course in Pediatric LRBA Deficiency. Journal of Clinical Immunology. 2026. doi:10.1007/s10875-026-02092-0
BibTeX
@article{Hu2026,
author = {Hu, Bin and Wang, Zhaoling and Zhang, Yan and Teng, Liping and Lu, Meiping},
title = {IDDA-Scored Abatacept-to-HSCT Course in Pediatric LRBA Deficiency},
journal = {Journal of Clinical Immunology},
year = {2026},
doi = {10.1007/s10875-026-02092-0}
}
EUVIMED